Wenhao Zhang, Dik C van Gent, Luca Incrocci, Wytske M van Weerden, Julie Nonnekens. Prostate Cancer Prostatic Dis 2020
Times Cited: 12
Times Cited: 12
Times Cited
Times Co-cited
Similarity
Endogenous DNA Damage as a Source of Genomic Instability in Cancer.
Anthony Tubbs, André Nussenzweig. Cell 2017
Anthony Tubbs, André Nussenzweig. Cell 2017
25
BRCA2 and Other DDR Genes in Prostate Cancer.
Paz Nombela, Rebeca Lozano, Alvaro Aytes, Joaquin Mateo, David Olmos, Elena Castro. Cancers (Basel) 2019
Paz Nombela, Rebeca Lozano, Alvaro Aytes, Joaquin Mateo, David Olmos, Elena Castro. Cancers (Basel) 2019
25
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.
Joaquin Mateo, Suzanne Carreira, Shahneen Sandhu, Susana Miranda, Helen Mossop, Raquel Perez-Lopez, Daniel Nava Rodrigues, Dan Robinson, Aurelius Omlin, Nina Tunariu,[...]. N Engl J Med 2015
Joaquin Mateo, Suzanne Carreira, Shahneen Sandhu, Susana Miranda, Helen Mossop, Raquel Perez-Lopez, Daniel Nava Rodrigues, Dan Robinson, Aurelius Omlin, Nina Tunariu,[...]. N Engl J Med 2015
25
Androgen receptor inhibitor-induced "BRCAness" and PARP inhibition are synthetically lethal for castration-resistant prostate cancer.
Likun Li, Styliani Karanika, Guang Yang, Jiangxiang Wang, Sanghee Park, Bradley M Broom, Ganiraju C Manyam, Wenhui Wu, Yong Luo, Spyridon Basourakos,[...]. Sci Signal 2017
Likun Li, Styliani Karanika, Guang Yang, Jiangxiang Wang, Sanghee Park, Bradley M Broom, Ganiraju C Manyam, Wenhui Wu, Yong Luo, Spyridon Basourakos,[...]. Sci Signal 2017
25
Androgen receptor signaling regulates DNA repair in prostate cancers.
William R Polkinghorn, Joel S Parker, Man X Lee, Elizabeth M Kass, Daniel E Spratt, Phillip J Iaquinta, Vivek K Arora, Wei-Feng Yen, Ling Cai, Deyou Zheng,[...]. Cancer Discov 2013
William R Polkinghorn, Joel S Parker, Man X Lee, Elizabeth M Kass, Daniel E Spratt, Phillip J Iaquinta, Vivek K Arora, Wei-Feng Yen, Ling Cai, Deyou Zheng,[...]. Cancer Discov 2013
25
Integrative clinical genomics of advanced prostate cancer.
Dan Robinson, Eliezer M Van Allen, Yi-Mi Wu, Nikolaus Schultz, Robert J Lonigro, Juan-Miguel Mosquera, Bruce Montgomery, Mary-Ellen Taplin, Colin C Pritchard, Gerhardt Attard,[...]. Cell 2015
Dan Robinson, Eliezer M Van Allen, Yi-Mi Wu, Nikolaus Schultz, Robert J Lonigro, Juan-Miguel Mosquera, Bruce Montgomery, Mary-Ellen Taplin, Colin C Pritchard, Gerhardt Attard,[...]. Cell 2015
25
DNA Repair in Prostate Cancer: Biology and Clinical Implications.
Joaquin Mateo, Gunther Boysen, Christopher E Barbieri, Helen E Bryant, Elena Castro, Pete S Nelson, David Olmos, Colin C Pritchard, Mark A Rubin, Johann S de Bono. Eur Urol 2017
Joaquin Mateo, Gunther Boysen, Christopher E Barbieri, Helen E Bryant, Elena Castro, Pete S Nelson, David Olmos, Colin C Pritchard, Mark A Rubin, Johann S de Bono. Eur Urol 2017
25
Prostate cancer and PARP inhibitors: progress and challenges.
Diego Teyssonneau, Henri Margot, Mathilde Cabart, Mylène Anonnay, Paul Sargos, Nam-Son Vuong, Isabelle Soubeyran, Nicolas Sevenet, Guilhem Roubaud. J Hematol Oncol 2021
Diego Teyssonneau, Henri Margot, Mathilde Cabart, Mylène Anonnay, Paul Sargos, Nam-Son Vuong, Isabelle Soubeyran, Nicolas Sevenet, Guilhem Roubaud. J Hematol Oncol 2021
25
The Identification of Potent, Selective, and Orally Available Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase: The Discovery of AZD0156 (8-{6-[3-(Dimethylamino)propoxy]pyridin-3-yl}-3-methyl-1-(tetrahydro-2 H-pyran-4-yl)-1,3-dihydro-2 H-imidazo[4,5- c]quinolin-2-one).
Kurt G Pike, Bernard Barlaam, Elaine Cadogan, Andrew Campbell, Yingxue Chen, Nicola Colclough, Nichola L Davies, Camila de-Almeida, Sebastien L Degorce, Myriam Didelot,[...]. J Med Chem 2018
Kurt G Pike, Bernard Barlaam, Elaine Cadogan, Andrew Campbell, Yingxue Chen, Nicola Colclough, Nichola L Davies, Camila de-Almeida, Sebastien L Degorce, Myriam Didelot,[...]. J Med Chem 2018
16
The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models.
Stephen T Durant, Li Zheng, Yingchun Wang, Kan Chen, Lingli Zhang, Tianwei Zhang, Zhenfan Yang, Lucy Riches, Antonio G Trinidad, Jacqueline H L Fok,[...]. Sci Adv 2018
Stephen T Durant, Li Zheng, Yingchun Wang, Kan Chen, Lingli Zhang, Tianwei Zhang, Zhenfan Yang, Lucy Riches, Antonio G Trinidad, Jacqueline H L Fok,[...]. Sci Adv 2018
16
Preclinical evaluation of a novel ATM inhibitor, KU59403, in vitro and in vivo in p53 functional and dysfunctional models of human cancer.
Michael A Batey, Yan Zhao, Suzanne Kyle, Caroline Richardson, Andrew Slade, Niall M B Martin, Alan Lau, David R Newell, Nicola J Curtin. Mol Cancer Ther 2013
Michael A Batey, Yan Zhao, Suzanne Kyle, Caroline Richardson, Andrew Slade, Niall M B Martin, Alan Lau, David R Newell, Nicola J Curtin. Mol Cancer Ther 2013
16
Ataxia telangiectasia and Rad3-related inhibitors and cancer therapy: where we stand.
Lin Mei, Junran Zhang, Kai He, Jingsong Zhang. J Hematol Oncol 2019
Lin Mei, Junran Zhang, Kai He, Jingsong Zhang. J Hematol Oncol 2019
16
Structural basis of homologous recombination.
Yueru Sun, Thomas J McCorvie, Luke A Yates, Xiaodong Zhang. Cell Mol Life Sci 2020
Yueru Sun, Thomas J McCorvie, Luke A Yates, Xiaodong Zhang. Cell Mol Life Sci 2020
16
PARP Inhibitors in Prostate and Urothelial Cancers.
Rohan Garje, Raju Kumar Vaddepally, Yousef Zakharia. Front Oncol 2020
Rohan Garje, Raju Kumar Vaddepally, Yousef Zakharia. Front Oncol 2020
22
The DNA damage response: making it safe to play with knives.
Alberto Ciccia, Stephen J Elledge. Mol Cell 2010
Alberto Ciccia, Stephen J Elledge. Mol Cell 2010
16
Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer.
Yi-Mi Wu, Marcin Cieślik, Robert J Lonigro, Pankaj Vats, Melissa A Reimers, Xuhong Cao, Yu Ning, Lisha Wang, Lakshmi P Kunju, Navonil de Sarkar,[...]. Cell 2018
Yi-Mi Wu, Marcin Cieślik, Robert J Lonigro, Pankaj Vats, Melissa A Reimers, Xuhong Cao, Yu Ning, Lisha Wang, Lakshmi P Kunju, Navonil de Sarkar,[...]. Cell 2018
16
The Cyclin K/Cdk12 complex maintains genomic stability via regulation of expression of DNA damage response genes.
Dalibor Blazek, Jiri Kohoutek, Koen Bartholomeeusen, Eric Johansen, Petra Hulinkova, Zeping Luo, Peter Cimermancic, Jernej Ule, B Matija Peterlin. Genes Dev 2011
Dalibor Blazek, Jiri Kohoutek, Koen Bartholomeeusen, Eric Johansen, Petra Hulinkova, Zeping Luo, Peter Cimermancic, Jernej Ule, B Matija Peterlin. Genes Dev 2011
16
Castration therapy results in decreased Ku70 levels in prostate cancer.
Firas L T Al-Ubaidi, Niklas Schultz, Olga Loseva, Lars Egevad, Torvald Granfors, Thomas Helleday. Clin Cancer Res 2013
Firas L T Al-Ubaidi, Niklas Schultz, Olga Loseva, Lars Egevad, Torvald Granfors, Thomas Helleday. Clin Cancer Res 2013
16
Recent Advances in Prostate Cancer Treatment and Drug Discovery.
Ekaterina Nevedomskaya, Simon J Baumgart, Bernard Haendler. Int J Mol Sci 2018
Ekaterina Nevedomskaya, Simon J Baumgart, Bernard Haendler. Int J Mol Sci 2018
16
Targeting DNA Damage Response in Prostate Cancer by Inhibiting Androgen Receptor-CDC6-ATR-Chk1 Signaling.
Styliani Karanika, Theodoros Karantanos, Likun Li, Jianxiang Wang, Sanghee Park, Guang Yang, Xuemei Zuo, Jian H Song, Sankar N Maity, Ganiraju C Manyam,[...]. Cell Rep 2017
Styliani Karanika, Theodoros Karantanos, Likun Li, Jianxiang Wang, Sanghee Park, Guang Yang, Xuemei Zuo, Jian H Song, Sankar N Maity, Ganiraju C Manyam,[...]. Cell Rep 2017
16
Alpha emitter radium-223 and survival in metastatic prostate cancer.
C Parker, S Nilsson, D Heinrich, S I Helle, J M O'Sullivan, S D Fosså, A Chodacki, P Wiechno, J Logue, M Seke,[...]. N Engl J Med 2013
C Parker, S Nilsson, D Heinrich, S I Helle, J M O'Sullivan, S D Fosså, A Chodacki, P Wiechno, J Logue, M Seke,[...]. N Engl J Med 2013
16
Coordination of DNA single strand break repair.
Rachel Abbotts, David M Wilson. Free Radic Biol Med 2017
Rachel Abbotts, David M Wilson. Free Radic Biol Med 2017
16
DNA Damage Response in Prostate Cancer.
Matthew J Schiewer, Karen E Knudsen. Cold Spring Harb Perspect Med 2019
Matthew J Schiewer, Karen E Knudsen. Cold Spring Harb Perspect Med 2019
16
CDK12-Altered Prostate Cancer: Clinical Features and Therapeutic Outcomes to Standard Systemic Therapies, Poly (ADP-Ribose) Polymerase Inhibitors, and PD-1 Inhibitors.
Emmanuel S Antonarakis, Pedro Isaacsson Velho, Wei Fu, Hao Wang, Neeraj Agarwal, Victor Sacristan Santos, Benjamin L Maughan, Roberto Pili, Nabil Adra, Cora N Sternberg,[...]. JCO Precis Oncol 2020
Emmanuel S Antonarakis, Pedro Isaacsson Velho, Wei Fu, Hao Wang, Neeraj Agarwal, Victor Sacristan Santos, Benjamin L Maughan, Roberto Pili, Nabil Adra, Cora N Sternberg,[...]. JCO Precis Oncol 2020
16
Darolutamide antagonizes androgen signaling by blocking enhancer and super-enhancer activation.
Simon J Baumgart, Ekaterina Nevedomskaya, Ralf Lesche, Richard Newman, Dominik Mumberg, Bernard Haendler. Mol Oncol 2020
Simon J Baumgart, Ekaterina Nevedomskaya, Ralf Lesche, Richard Newman, Dominik Mumberg, Bernard Haendler. Mol Oncol 2020
18
Pharmacology of the ATM Inhibitor AZD0156: Potentiation of Irradiation and Olaparib Responses Preclinically.
Lucy C Riches, Antonio G Trinidad, Gareth Hughes, Gemma N Jones, Adina M Hughes, Andrew G Thomason, Paul Gavine, Andy Cui, Stephanie Ling, Jonathan Stott,[...]. Mol Cancer Ther 2020
Lucy C Riches, Antonio G Trinidad, Gareth Hughes, Gemma N Jones, Adina M Hughes, Andrew G Thomason, Paul Gavine, Andy Cui, Stephanie Ling, Jonathan Stott,[...]. Mol Cancer Ther 2020
16
Targeting the TLK1/NEK1 DDR axis with Thioridazine suppresses outgrowth of androgen independent prostate tumors.
Vibha Singh, Praveen Kumar Jaiswal, Ishita Ghosh, Hari K Koul, Xiuping Yu, Arrigo De Benedetti. Int J Cancer 2019
Vibha Singh, Praveen Kumar Jaiswal, Ishita Ghosh, Hari K Koul, Xiuping Yu, Arrigo De Benedetti. Int J Cancer 2019
16
Dysregulated Transcriptional Control in Prostate Cancer.
Simon J Baumgart, Ekaterina Nevedomskaya, Bernard Haendler. Int J Mol Sci 2019
Simon J Baumgart, Ekaterina Nevedomskaya, Bernard Haendler. Int J Mol Sci 2019
16
The DNA Damaging Revolution: PARP Inhibitors and Beyond.
Timothy A Yap, Ruth Plummer, Nilofer S Azad, Thomas Helleday. Am Soc Clin Oncol Educ Book 2019
Timothy A Yap, Ruth Plummer, Nilofer S Azad, Thomas Helleday. Am Soc Clin Oncol Educ Book 2019
16
Identification of Novel Biomarkers of Homologous Recombination Defect in DNA Repair to Predict Sensitivity of Prostate Cancer Cells to PARP-Inhibitors.
Daniela Criscuolo, Francesco Morra, Riccardo Giannella, Aniello Cerrato, Angela Celetti. Int J Mol Sci 2019
Daniela Criscuolo, Francesco Morra, Riccardo Giannella, Aniello Cerrato, Angela Celetti. Int J Mol Sci 2019
16
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.
Colin C Pritchard, Joaquin Mateo, Michael F Walsh, Navonil De Sarkar, Wassim Abida, Himisha Beltran, Andrea Garofalo, Roman Gulati, Suzanne Carreira, Rosalind Eeles,[...]. N Engl J Med 2016
Colin C Pritchard, Joaquin Mateo, Michael F Walsh, Navonil De Sarkar, Wassim Abida, Himisha Beltran, Andrea Garofalo, Roman Gulati, Suzanne Carreira, Rosalind Eeles,[...]. N Engl J Med 2016
16
16
Genomic rearrangements in prostate cancer.
Christopher E Barbieri, Mark A Rubin. Curr Opin Urol 2015
Christopher E Barbieri, Mark A Rubin. Curr Opin Urol 2015
16
16
16
Targeted Next-Generation Sequencing in Men with Metastatic Prostate Cancer: a Pilot Study.
Pedro C Barata, Prateek Mendiratta, Brandie Heald, Stefan Klek, Petros Grivas, Davendra P S Sohal, Jorge A Garcia. Target Oncol 2018
Pedro C Barata, Prateek Mendiratta, Brandie Heald, Stefan Klek, Petros Grivas, Davendra P S Sohal, Jorge A Garcia. Target Oncol 2018
22
Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial.
Joaquin Mateo, Nuria Porta, Diletta Bianchini, Ursula McGovern, Tony Elliott, Robert Jones, Isabel Syndikus, Christy Ralph, Suneil Jain, Mohini Varughese,[...]. Lancet Oncol 2020
Joaquin Mateo, Nuria Porta, Diletta Bianchini, Ursula McGovern, Tony Elliott, Robert Jones, Isabel Syndikus, Christy Ralph, Suneil Jain, Mohini Varughese,[...]. Lancet Oncol 2020
16
16
Genomics of lethal prostate cancer at diagnosis and castration resistance.
Joaquin Mateo, George Seed, Claudia Bertan, Pasquale Rescigno, David Dolling, Ines Figueiredo, Susana Miranda, Daniel Nava Rodrigues, Bora Gurel, Matthew Clarke,[...]. J Clin Invest 2020
Joaquin Mateo, George Seed, Claudia Bertan, Pasquale Rescigno, David Dolling, Ines Figueiredo, Susana Miranda, Daniel Nava Rodrigues, Bora Gurel, Matthew Clarke,[...]. J Clin Invest 2020
16
AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer.
Emmanuel S Antonarakis, Changxue Lu, Hao Wang, Brandon Luber, Mary Nakazawa, Jeffrey C Roeser, Yan Chen, Tabrez A Mohammad, Yidong Chen, Helen L Fedor,[...]. N Engl J Med 2014
Emmanuel S Antonarakis, Changxue Lu, Hao Wang, Brandon Luber, Mary Nakazawa, Jeffrey C Roeser, Yan Chen, Tabrez A Mohammad, Yidong Chen, Helen L Fedor,[...]. N Engl J Med 2014
16
A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling.
Eric A Klein, Matthew R Cooperberg, Cristina Magi-Galluzzi, Jeffry P Simko, Sara M Falzarano, Tara Maddala, June M Chan, Jianbo Li, Janet E Cowan, Athanasios C Tsiatis,[...]. Eur Urol 2014
Eric A Klein, Matthew R Cooperberg, Cristina Magi-Galluzzi, Jeffry P Simko, Sara M Falzarano, Tara Maddala, June M Chan, Jianbo Li, Janet E Cowan, Athanasios C Tsiatis,[...]. Eur Urol 2014
16
Genomic Alteration Burden in Advanced Prostate Cancer and Therapeutic Implications.
Matthew J Ryan, Rohit Bose. Front Oncol 2019
Matthew J Ryan, Rohit Bose. Front Oncol 2019
16
Mechanisms of DNA damage, repair, and mutagenesis.
Nimrat Chatterjee, Graham C Walker. Environ Mol Mutagen 2017
Nimrat Chatterjee, Graham C Walker. Environ Mol Mutagen 2017
16
Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study.
Andrew J Armstrong, Susan Halabi, Jun Luo, David M Nanus, Paraskevi Giannakakou, Russell Z Szmulewitz, Daniel C Danila, Patrick Healy, Monika Anand, Colin J Rothwell,[...]. J Clin Oncol 2019
Andrew J Armstrong, Susan Halabi, Jun Luo, David M Nanus, Paraskevi Giannakakou, Russell Z Szmulewitz, Daniel C Danila, Patrick Healy, Monika Anand, Colin J Rothwell,[...]. J Clin Oncol 2019
16
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
16
Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth.
David J Mulholland, Linh M Tran, Yunfeng Li, Houjian Cai, Ashkan Morim, Shunyou Wang, Seema Plaisier, Isla P Garraway, Jiaoti Huang, Thomas G Graeber,[...]. Cancer Cell 2011
David J Mulholland, Linh M Tran, Yunfeng Li, Houjian Cai, Ashkan Morim, Shunyou Wang, Seema Plaisier, Isla P Garraway, Jiaoti Huang, Thomas G Graeber,[...]. Cancer Cell 2011
16
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.